These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 912880)

  • 21. Interference by danazol with the Porter-Silber method for determination of urinary 17-hydroxycorticosteroids.
    Konishi H; Minouchi T; Yamaji A
    Ann Clin Biochem; 2001 May; 38(Pt 3):277-9. PubMed ID: 11392505
    [No Abstract]   [Full Text] [Related]  

  • 22. Does chlorpromazine interfere with the Porter-Silber reaction?
    Ellman GL
    Clin Chim Acta; 1971 Nov; 35(1):79-82. PubMed ID: 5127009
    [No Abstract]   [Full Text] [Related]  

  • 23. A method for determining nitrofurantoin in urine in the presence of phenazopyridine hydrochloride and its metabolites.
    Hollifield RD; Conklin JD
    Clin Chem; 1970 Apr; 16(4):335-8. PubMed ID: 5445351
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of routine methods, based on Porter-Silber color reaction, for estimation of urinary 17-hydroxycorticosteroids.
    KORNEL L; HILL SR
    Metabolism; 1960 Sep; 9():853-60. PubMed ID: 14411066
    [No Abstract]   [Full Text] [Related]  

  • 25. 17-Hydroxycorticosteroids in urine.
    Simon M; Babich-Armstrong M
    Clin Chim Acta; 1980 Apr; 103(1):101-8. PubMed ID: 7389110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefoxitin: another Porter-Silber chromogen.
    Giacalone M; Tomycz NB; Caraway WT
    South Med J; 1985 Apr; 78(4):493. PubMed ID: 3983676
    [No Abstract]   [Full Text] [Related]  

  • 27. A modification of Silber-Porter method for urinary 17-hydroxycorticosteroids conjugated with glucuronic acid.
    KORNEL L
    Metabolism; 1960 Jan; 9():82-4. PubMed ID: 14411067
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of urinary acidifiers on formaldehyde concentration and efficacy with methenamine therapy.
    Nahata MC; Cummins BA; McLeod DC; Schondelmeyer SW; Butler R
    Eur J Clin Pharmacol; 1982; 22(3):281-4. PubMed ID: 7106162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fluorometric cortisol determination with Spekol. Advantages of 11-hydroxycorticosteroid determination as compared to determination of ketogenic steroids and free Porter-Silber chromogens].
    Woltersdorf W
    Z Med Labortech; 1970; 11(6):366-72. PubMed ID: 5514094
    [No Abstract]   [Full Text] [Related]  

  • 30. [PRELIMINARY STUDY OF THE EFFECTS OF TUBERCULIN THERAPY ON THE EXCRETION OF URINARY 17-HYDROXYCORTICOSTEROIDS (METHODS OF PORTER AND SILBER)].
    JUNET R; HAMSAG X
    Helv Med Acta; 1964 Nov; 31():469-72. PubMed ID: 14335452
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study on 17-OHCS in the urine: on color development of the Porter-Silber reaction].
    Motohashi K
    Horumon To Rinsho; 1965 Nov; 13(11):889-93. PubMed ID: 5895313
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of effect of ascorbic acid, hippuric acid, and methenamine (urinary formaldehyde) on the copper-reduction glucose test in geriatric patients.
    Nahata MC; McLeod DC
    J Am Geriatr Soc; 1980 May; 28(5):230-3. PubMed ID: 7365188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigations on the estimation of 17-hydroxycorticoids in urine using the Porter/Silber reaction.
    VESTERGAARD P
    Acta Endocrinol (Copenh); 1953 Jul; 13(3):241-64. PubMed ID: 13079557
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous determination of methenamine and formaldehyde in the urine of humans after methenamine administration.
    Gollamudi R; Meyer MC; Straughn AB
    Biopharm Drug Dispos; 1979; 1(1):27-36. PubMed ID: 552858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary excretion of methenamine and formaldehyde: evaluation of 10 methenamine products in humans.
    Gollamudi R; Straughn AB; Meyer MC
    J Pharm Sci; 1981 Jun; 70(6):596-9. PubMed ID: 7252798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free urinary cortisol as a representative steroid of the urinary Porter-Silber-chromogens.
    Stolecke H
    Acta Endocrinol (Copenh); 1972 May; 70(1):65-72. PubMed ID: 4338051
    [No Abstract]   [Full Text] [Related]  

  • 37. Interference by methenamine mandelate in screening for organic and amino acid disorders.
    Roesel RA; Coryell ME; Blankenship PR; Thevaos TG; Hall WK
    Clin Chim Acta; 1980 Jan; 100(1):55-8. PubMed ID: 7351078
    [No Abstract]   [Full Text] [Related]  

  • 38. The antimicrobial activity of urine of paraplegic patients receiving methenamine mandelate.
    Pearman JW; Peterson GJ; Nash JB
    Invest Urol; 1978 Sep; 16(2):91-8. PubMed ID: 30734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A MODIFIED PROCEDURE FOR THE ESTIMATION OF TOTAL 17-HYDROXYCORTICOSTEROIDS (PORTER-SILBER CHROMOGENS) IN URINE.
    LIU JH
    Clin Chem; 1964 Feb; 10():103-15. PubMed ID: 14132226
    [No Abstract]   [Full Text] [Related]  

  • 40. Ascorbic acid and methenamine mandelate on the urinary pH of spinal cord injury patients.
    Lamid S
    J Urol; 1983 Apr; 129(4):845-6. PubMed ID: 6842722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.